SG Americas Securities’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.79M Sell
73,088
-64,061
-47% -$7.76M ﹤0.01% 924
2026
Q1
$22.4M Buy
137,149
+70,387
+105% +$10.8M 0.02% 497
2025
Q4
$11.6M Buy
66,762
+49,356
+284% +$9.01M 0.01% 698
2025
Q3
$2.51M Buy
17,406
+13,305
+324% +$1.63M 0.01% 830
2025
Q2
$413K Sell
4,101
-94
-2% -$7.19K ﹤0.01% 1792
2025
Q1
$320K Sell
4,195
-680
-14% -$52K ﹤0.01% 2158
2024
Q4
$337K Sell
4,875
-16,686
-77% -$1.2M ﹤0.01% 1683
2024
Q3
$1.57M Buy
21,561
+19,084
+770% +$1.41M 0.01% 786
2024
Q2
$166K Sell
2,477
-6,031
-71% -$234K ﹤0.01% 2267
2024
Q1
$231K Buy
8,508
+4,695
+123% +$131K ﹤0.01% 1875
2023
Q4
$118K Sell
3,813
-1,715
-31% -$44.5K ﹤0.01% 2633
2023
Q3
$140K Sell
5,528
-166,225
-97% -$3.8M ﹤0.01% 2557
2023
Q2
$3.62M Buy
171,753
+116,601
+211% +$2.21M 0.03% 492
2023
Q1
$940K Buy
55,152
+44,838
+435% +$871K 0.01% 1179
2022
Q4
$206K Sell
10,314
-6,774
-40% -$131K ﹤0.01% 2173
2022
Q3
$368K Sell
17,088
-43,810
-72% -$1.05M ﹤0.01% 1813
2022
Q2
$1.2M Buy
60,898
+50,539
+488% +$1.06M 0.01% 1137
2022
Q1
$243K Sell
10,359
-34,105
-77% -$792K ﹤0.01% 2308
2021
Q4
$1.21M Sell
44,464
-32,547
-42% -$931K 0.01% 1500
2021
Q3
$2.12M Buy
77,011
+43,618
+131% +$1.14M 0.01% 1214
2021
Q2
$950K Buy
33,393
+24,259
+266% +$720K ﹤0.01% 1592
2021
Q1
$311K Buy
9,134
+5,898
+182% +$225K ﹤0.01% 2353
2020
Q4
$108K Sell
3,236
-29,572
-90% -$1.08M ﹤0.01% 2997
2020
Q3
$1.05M Buy
32,808
+17,516
+115% +$503K 0.01% 1144
2020
Q2
$421K Sell
15,292
-5,029
-25% -$119K ﹤0.01% 2241
2020
Q1
$326K Buy
20,321
+16,029
+373% +$380K ﹤0.01% 2167
2019
Q4
$102K Buy
+4,292
New +$87.3K ﹤0.01% 2950
2019
Q2
Sell
-4,492
Closed -$131K 3251
2019
Q1
$131K Sell
4,492
-12,326
-73% -$319K ﹤0.01% 2871
2018
Q4
$221K Buy
+16,818
New +$268K ﹤0.01% 2334
2018
Q3
Sell
-4,480
Closed -$106K 3299
2018
Q2
$106K Sell
4,480
-658
-13% -$16.9K ﹤0.01% 3040
2018
Q1
$116K Buy
+5,138
New +$135K ﹤0.01% 2834
2017
Q4
Sell
-14,289
Closed -$446K 3407
2017
Q3
$446K Buy
14,289
+6,786
+90% +$129K ﹤0.01% 1933
2017
Q2
$129K Buy
+7,503
New +$128K ﹤0.01% 2739
2017
Q1
Sell
-23,983
Closed -$317K 3409
2016
Q4
$317K Buy
+23,983
New +$327K ﹤0.01% 1995
2015
Q4
Sell
-9,478
Closed -$176K 2838
2015
Q3
$176K Buy
9,478
+4,940
+109% +$123K ﹤0.01% 1528
2015
Q2
$111K Buy
+4,538
New +$103K ﹤0.01% 2306
2015
Q1
Sell
-7,589
Closed -$117K 2791
2014
Q4
$117K Buy
+7,589
New +$108K ﹤0.01% 2812

Other funds holding INSM

SG Americas Securities's INSM Position: Q2 2026 in Review

SG Americas Securities reduced its Insmed (INSM) stake by 47% in Q2 2026, selling an estimated $7.76M and leaving 73,088 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #924.

SG Americas Securities first reported a position in INSM in Q4 2014 and has held it in 37 quarters since. The position peaked at $22.4M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • SG Americas Securities held 73,088 shares of Insmed worth $7.79M as of Q2 2026.
  • SG Americas Securities sold 64,061 Insmed shares in Q2 2026, an estimated $7.76M.
  • Insmed made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #924 holding.
  • SG Americas Securities first reported a position in Insmed in Q4 2014 and has held it in 37 quarters since.
  • SG Americas Securities's Insmed position peaked at $22.4M in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.